We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
(Approval lapsed) VERSACLOZ (clozapine) 50 mg/mL oral suspension (Jazz Pharmaceuticals)
Section 19A approved medicine
(Approval lapsed) VERSACLOZ (clozapine) 50 mg/mL oral suspension (Jazz Pharmaceuticals)
Section 19A approval holder
Pfizer Australia Pty Ltd ABN 50 00 8422 348
Phone
1800 675 229
Approved until
Status
Expired
Medicines in short supply/unavailable
CLOPINE SUSPENSION clozapine 50 mg/mL oral liquid bottle - ARTG 142239
Indication(s)
Treatment with VERSACLOZ is indicated only in people with treatment-resistant schizophrenia, ie. people with schizophrenia who are non-responsive to, or intolerant of other antipsychotic drugs.